Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$981,789
-$128,578 QoQ
Shares Held
40,772
+3.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#1,336
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Van Hulzen Asset Management, LLC holds $51,223,577 across 8 Drug Manufacturers - General names. PFE ranks #7 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
118,886 | $30,193,477 | |
| 2 | ABBV |
AbbVie Inc.
|
45,296 | $11,398,285 | |
| 3 | LLY |
ELI LILLY & Co
|
2,080 | $2,494,814 | |
| 4 | AMGN |
Amgen Inc
|
6,577 | $2,381,663 | |
| 5 | MRK |
Merck & Co., Inc.
|
13,759 | $1,768,031 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
8,160 | $1,030,934 | |
| 7 | PFE |
Pfizer Inc
This page
|
40,772 | $981,789 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
16,914 | $974,584 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $981,789 | 40,772 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,110,367 | 39,543 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $896,175 | 35,991 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $627,037 | 24,609 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $596,352 | 24,602 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $621,894 | 24,542 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $629,079 | 23,712 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $953,486 | 32,947 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $789,203 | 28,206 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $698,550 | 25,173 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $766,332 | 26,618 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $888,690 | 26,792 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $2,205,715 | 60,134 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $2,131,024 | 52,231 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $1,239,034 | 24,181 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,008,886 | 23,055 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,261,570 | 24,062 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $1,214,368 | 23,457 | Shares | Sole | 2022-05-20 | |
| 2021-12-31 | $1,591,220 | 26,947 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $1,253,784 | 29,151 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,133,682 | 28,950 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $857,745 | 23,675 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $2,215,373 | 60,184 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $8,762,593 | 238,763 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $8,609,559 | 263,289 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $7,794,356 | 238,798 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||